Thiazolidinediones and their Drug Interactions involving 
CYP enzymes

Naina Mohamed##Pakkir Maideen|

2020, Vol: 10, Issue: 2

10 / 2Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

« Previous Article

Review Article

A J Physiol Biochem Pharmacol. 2018; 8(2): 47-54

doi: 10.5455/ajpbp.20181022083057

Thiazolidinediones and their Drug Interactions involving CYP enzymes

Naina Mohamed Pakkir Maideen.

Cited by (1)

Abstract
Background:
Thiazolidinediones (TZDs) include Pioglitazone and Rosiglitazone and they are indicated in the treatment of type 2 diabetes mellitus. They are insulin sensitizers and are metabolised primarily by CYP2C8 enzyme. The drugs inhibiting or inducing CYP2C8 enzyme may result in pharmacokinetic drug interactions of TZDs. The probability of drug interactions is higher in type 2 diabetic patients as they administer many medications to manage blood glucose and to treat other diseases. Clinically significant drug interactions of TZDs are discussed in this review.
Methods:
The literature review was done in databases like Medline/PubMed/PMC, Science Direct, Google scholar, Directory of open access journals (DOAJ), and reference lists to identify relevant articles.
Results:
The drugs inhibiting the CYP2C8 enzyme such as Gemfibrozil, Clopidogrel, Trimethoprim, Ketoconazole and Rifampicin have been identified to affect the pharmacokinetics of TZDs.
Conclusion:
The clinicians need to be aware of adverse drug interactions of TZDs to prevent negative outcomes.

Key words: Drug interactions; Thiazolidinedione antidiabetics; Pioglitazone; Rosiglitazone; CYP2C8; CYP2C9.

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Naina Mohamed Pakkir Maideen
	on Google
	on Google Scholar
	Article Statistics
	Viewed: 3316 Downloaded: 210 Cited: 1

This Article Cited By the following articles

Drug interactions of dipeptidyl peptidase 4 inhibitors involving CYP enzymes and P-gp efflux pump WJMA 2019; 7(4): 156.	1

How to Cite this Article

Pubmed Style

Maideen NMP, . Thiazolidinediones and their Drug Interactions involving CYP enzymes . A J Physiol Biochem Pharmacol. 2018; 8(2): 47-54. doi:10.5455/ajpbp.20181022083057

Web Style

Maideen NMP, . Thiazolidinediones and their Drug Interactions involving CYP enzymes . http://www.ajpbp.com/?mno=12698 [Access: February 15, 2020]. doi:10.5455/ajpbp.20181022083057

AMA (American Medical Association) Style

Maideen NMP, . Thiazolidinediones and their Drug Interactions involving CYP enzymes . A J Physiol Biochem Pharmacol. 2018; 8(2): 47-54. doi:10.5455/ajpbp.20181022083057

Vancouver/ICMJE Style

Maideen NMP, . Thiazolidinediones and their Drug Interactions involving CYP enzymes . A J Physiol Biochem Pharmacol. (2018), [cited February 15, 2020]; 8(2): 47-54. doi:10.5455/ajpbp.20181022083057

Harvard Style

Maideen, N. M. . P. & (2018) Thiazolidinediones and their Drug Interactions involving CYP enzymes . A J Physiol Biochem Pharmacol, 8 (2), 47-54. doi:10.5455/ajpbp.20181022083057

Turabian Style

Maideen, Naina Mohamed Pakkir, and . 2018. Thiazolidinediones and their Drug Interactions involving CYP enzymes . American Journal of Physiology, Biochemistry and Pharmacology, 8 (2), 47-54. doi:10.5455/ajpbp.20181022083057

Chicago Style

Maideen, Naina Mohamed Pakkir, and . "Thiazolidinediones and their Drug Interactions involving CYP enzymes ." American Journal of Physiology, Biochemistry and Pharmacology 8 (2018), 47-54. doi:10.5455/ajpbp.20181022083057

MLA (The Modern Language Association) Style

APA (American Psychological Association) Style

Maideen, N. M. . P. & (2018) Thiazolidinediones and their Drug Interactions involving CYP enzymes . American Journal of Physiology, Biochemistry and Pharmacology, 8 (2), 47-54. doi:10.5455/ajpbp.20181022083057